Regional News

Turn Biotechnologies Changes Paradigm in Skin Rejuvenation

* Data unveiled at four industry conferences suggest a single ERA treatment may be more effective than combination therapies used today * Biomarker analysis demonstrates ERA's regenerative impact on fibroblast proliferation, collagen VII production * eTurna™ lipid-based delivery platform p...

2022-12-06 22:00 3978

Midco launches rock-solid in-home wireless powered by Plume HomePass and OpenSync

Next-generation managed Wi-Fi solution puts more power in customers' hands SIOUX FALLS, S.D., Dec. 6, 2022 /PRNewswire/ -- Midco® is enhancing the home internet experience by introducing Midco Wi-Fi powered byPlume HomePass®. This next-gen Wi-Fi service is fueled by cloud, artificial intelligenc...

2022-12-06 22:00 2780

AIRCUVE introduces Smart 2FA Security platform for Work-From-Home Optimized

SEOUL, South Korea, Dec. 6, 2022 /PRNewswire/ -- AirCUVE, during the last 2 decades as a global leading network security company, launched a Smart two-factor Authentication Solution, V-FRONT v7, which is an advanced Smart and Easy Login solution in November. The long-lasting COVID-19 changed work...

2022-12-06 22:00 2824

Amorepacific and BTS collaborate to release limited-edition set featuring NEW "Butter" Lip Sleeping Mask flavor

* Amorepacific launches limited edition BTS | Amorepacific Lip Sleeping Mask Lip & Pop Edition * This second partnership celebrates 3 of BTS' most popular releases: "Butter," "Permission to Dance," and "Dynamite" paired with 3 LANEIGE Lip Sleeping Mask flavors. SEOUL, South Korea, Dec. 6, 202...

2022-12-06 22:00 2994

COP15: An International Conference on Solutions to the Underlying Causes of Biodiversity Loss

MONTREAL, Dec. 6, 2022 /PRNewswire/ -- The COP15 on Biodiversity, to be held in Montreal from December 7 to 19, 2022, is a unique opportunity to debate issues related to the protection of nature. CollectifCOP15, a collective of 94 Quebec civil society organizations, is organizing a major internat...

2022-12-06 21:30 2641

Adhering to the Concept of "Users First", OMODA 5 Sincerely Invites Australian Users to Meet in the Livestreaming Event

CANBERRA, Australia, Dec. 6, 2022 /PRNewswire/ -- OMODA 5 has attracted the attention of numerous media outlets and users since it launched inAustralia and New Zealand. In particular, some fans took pictures of the road test of OMODA 5 inVictoria a few days ago, which inspired everyone's strong c...

2022-12-06 21:30 3163

EZGO Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirements

No Immediate Effect on Nasdaq Listing or Trading of EZGO's Ordinary Shares CHANGZHOU, China, Dec. 6, 2022 /PRNewswire/ -- EZGO Technologies Ltd. (Nasdaq: EZGO) ("EZGO" or the "Company"), a leading short-distance transportation solutions provider inChina, today announced that it has received a no...

2022-12-06 21:30 3906

Newtown's Apple to Highly Saturated Global Molecular Market, TIANGEN TGuide S16 Automated Nucleic Acid Extractor Showcased at Cell Bio 2022

WASHINGTON, Dec. 6, 2022 /PRNewswire/ -- TIANGEN, a high-tech biological enterprise, demonstrated its revolutionary nucleic acid extraction solution at Cell Bio 2022, the joint meeting of the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO), fromDec 4 to...

2022-12-06 21:04 2319

Industrial and Manufacturing Contributed US$16 Trillion Worth of Value to the Worldwide Economy in 2021

ABI Research's latest manufacturing market data report provides an up-to-date and detailed view of the global manufacturing landscape with deep dives into key regions and verticals NEW YORK, Dec. 6, 2022 /PRNewswire/ -- The industrial and manufacturing world has seen significant change over the ...

2022-12-06 21:03 2441

Akeso Inc. Announces Collaboration and License Agreement for Up to US$5 Billion with Summit Therapeutics to Accelerate Global Development and Commercialization of its Breakthrough Bispecific Antibody, Ivonescimab (PD-1/VEGF)

* Akeso Inc. to out-license to Summit Therapeutics exclusive rights to ivonescimab (PD-1/VEGF) for the development and commercialization inthe United States, Canada, Europe, and Japan. Akeso Inc. will retain development and commercialization rights for the rest of the world includingChina. * ...

2022-12-06 21:01 3183

New High-Volume Farmmi Order to Israel

LISHUI, China, Dec. 6, 2022 /PRNewswire/ -- Farmmi, Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI), an agricultural products supplier inChina, today announced a new high volume order which will ship toIsrael. The latest repeat order comes from one of Farmmi's long-term customers and is for the C...

2022-12-06 21:00 3950

inVia Robotics Earns Frost & Sullivan's 2022 North American Technology Innovation Leadership Award for Its Highly Differentiated Products and Robotics-as-a-service Model

By automating iterative tasks and delivering first-class AI-based optimization software, inVia Robotics dramatically increases the productivity and accuracy of warehouses. SAN ANTONIO, Dec. 6, 2022 /PRNewswire/ -- Based on its recent analysis of the North American Goods-to-person Robotics Techno...

2022-12-06 21:00 2327

Spiers New Technologies Recognized by Frost & Sullivan for Its Market Leadership in the Electric Vehicle Battery 4R Services Industry

Spiers New Technologies delivers reliable battery management solutions to increase battery lifespan and performance. SAN ANTONIO, Dec. 6, 2022 /PRNewswire/ -- Based on its recent analysis of the electric vehicle battery 4R services Industry,Frost & Sullivan recognizes Spiers New Technologies (SN...

2022-12-06 21:00 2535

Delta Controls Applauded by Frost & Sullivan for Its Innovative, Customer-centric Products and Competitive Strategy in Building Automation

Delta Controls is process-driven and identifies and addresses customers' needs to build and sustain solid, strategic partnerships while its state-of-the-art products save energy, effort, and time. SAN ANTONIO, Dec. 6, 2022 /PRNewswire/ -- Frost & Sullivan recently assessed the Internet of Things...

2022-12-06 21:00 2596

Dubai-based DAMAC Group signs contract with Mandarin Oriental to manage luxurious resort in The Maldives

* 34-hectare resort is DAMAC Group's first project in the Maldives * Hotel adds to DAMAC's prestigious portfolio which has been successfully expanding internationally * DAMAC Group's partnerships with renowned brands such as Mandarin Oriental is a testament to its brand equity and position i...

2022-12-06 20:42 4644

APJ Financial Services: Akamai Research Shows APJ Surpasses North America in Web Application and API Cyberattacks Against Financial Services

State of the Internet report shows web application and API cyberattacks grew by 449 percent year-over-year in APJ, from 50M in 2021 to 240M in 2022 SINGAPORE, Dec. 6, 2022 /PRNewswire/ -- Akamai Technologies, Inc. (NASDAQ: AKAM), the cloud company that powers and protects life online, today relea...

2022-12-06 20:35 3051

BTMIN Risk Precautions: How To Identify Hyper-realistic Scam SMS Saying "Relief Subsidy"

SINGAPORE, Dec. 6, 2022 /PRNewswire/ -- It is reported that recently, a female netizen posted a screenshot of an SMS on Dcard. At first glance, it appeared to be a relief SMS notification from the Ministry of Health and Welfare. The original PO wrote, "I click the link by instinct, but it is real...

2022-12-06 20:28 2117

H3C AD-WAN Solution Helps LiveCom's Global SD-WAN Operation

KUALA LUMPUR, Malaysia, Dec. 6, 2022 /PRNewswire/ -- According to Omdia's report, the compound growth rate of the global SD-WAN market will reach 11.9% from 2021 to 2027, and the market size will exceedUSD 10 billion by 2027, continuing to lead the enterprise network service market. In recent yea...

2022-12-06 20:18 2724

CORVIA MEDICAL ANNOUNCES RANDOMIZATION OF FIRST PATIENT IN THE RESPONDER-HF CONFIRMATORY TRIAL

Corvia® Atrial Shunt has the potential to change the way heart failure is treated TEWKSBURY, Mass., Dec. 6, 2022 /PRNewswire/ -- Corvia Medical, Inc., a company dedicated to transforming the treatment of heart failure (HF), announced the first patient has been randomized in RESPONDER-HF, a globa...

2022-12-06 20:04 1922

Daewoong Pharmaceutical announces success in developing a new antidiabetic medication and its aims to enter the market in over 50 countries by 2030

* Delivers new drug for two consecutive years by obtaining product license on "Envlo", Korea's 36th new drug from the Ministry of Food and Drug Safety * Plans to enter the type 2 diabetes global market worth $71.4 billion * Provides new and broad treatment options for patients with insufficie...

2022-12-06 20:00 2196

Week's Top Stories